{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:32:21Z","timestamp":1773682341579,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007830","name":"Kitasato University","doi-asserted-by":"publisher","award":["18-1"],"award-info":[{"award-number":["18-1"]}],"id":[{"id":"10.13039\/501100007830","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbrc.2009.11.043","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T05:10:37Z","timestamp":1258002637000},"page":"242-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis"],"prefix":"10.1016","volume":"391","author":[{"given":"Etsuro","family":"Ohta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiya","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2009.11.043_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","article-title":"A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2\u2013q13.1","volume":"51","author":"Funayama","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2009.11.043_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal\u2013dominant Parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2009.11.043_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2009.11.043_bib4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.20484","article-title":"An LRRK2 mutation as a cause for the Parkinsonism in the original PARK8 family","volume":"57","author":"Funayama","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2009.11.043_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tibs.2005.01.003","article-title":"The RIP kinases: crucial integrators of cellular stress","volume":"30","author":"Meylan","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2009.11.043_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2007.02.086","article-title":"Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson\u2019s disease families","volume":"417","author":"Ohta","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2009.11.043_bib7","unstructured":"U. Kumari, E.K. Tan, LRRK2 in Parkinson\u2019s disease: genetic and clinical studies from patients, FEBS J., in press."},{"key":"10.1016\/j.bbrc.2009.11.043_bib8","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.11.043_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","article-title":"The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity","volume":"15","author":"Gloeckner","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2009.11.043_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2009.11.043_bib11","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddm151","article-title":"Mechanistic insight into the dominant mode of the Parkinson\u2019s disease-associated G2019S LRRK2 mutation","volume":"16","author":"Luzon-Toro","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2009.11.043_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","article-title":"Kinase activity of mutant LRRK2 mediates neuronal toxicity","volume":"9","author":"Smith","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2009.11.043_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","article-title":"The familial Parkinsonism gene LRRK2 regulates neurite process morphology","volume":"52","author":"Macleod","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2009.11.043_bib14","unstructured":"S. Sen, P.J. Webber, A.B. West, Leucine-rich repeat kinase 2 (LRRK2) kinase activity: dependence on dimerization, J. Biol. Chem., in press."},{"key":"10.1016\/j.bbrc.2009.11.043_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson\u2019s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2009.11.043_bib16","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/emboj.2008.163","article-title":"Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila","volume":"27","author":"Imai","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2009.11.043_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20070209","article-title":"LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson\u2019s disease mutants affect kinase activity","volume":"405","author":"Jaleel","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2009.11.043_bib18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1742-4658.2008.06789.x","article-title":"Investigation of leucine-rich repeat kinase 2: enzymological properties and novel assays","volume":"276","author":"Anand","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2009.11.043_bib19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbrc.2009.10.034","article-title":"I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson\u2019s disease, has a higher intracellular degradation rate than the wild-type molecule","volume":"390","author":"Ohta","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2009.11.043_bib20","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-004-0167-2","article-title":"Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress","volume":"111","author":"Mytilineou","year":"2004","journal-title":"Neural Transm."},{"key":"10.1016\/j.bbrc.2009.11.043_bib21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1158\/1535-7163.MCT-06-0541","article-title":"A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells","volume":"6","author":"Ding","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2009.11.043_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.toxlet.2008.02.003","article-title":"Chloroquine-induced nitric oxide increase and cell death is dependent on cellular GSH depletion in A172 human glioblastoma cells","volume":"178","author":"Park","year":"2008","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrc.2009.11.043_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1471-4159.2003.02152.x","article-title":"Proteasome inhibition and aggregation in Parkinson\u2019s disease: a comparative study in untransfected and transfected cells","volume":"88","author":"Biasini","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2009.11.043_bib24","doi-asserted-by":"crossref","first-page":"11320","DOI":"10.1074\/jbc.M412441200","article-title":"Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations","volume":"280","author":"Fioriti","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.11.043_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1042\/BJ20051197","article-title":"Catabolism of endogenous and overexpressed APH1a and PEN2: evidence for artifactual involvement of the proteasome in the degradation of overexpressed proteins","volume":"394","author":"Dunys","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2009.11.043_bib26","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","article-title":"Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin and mutant LRRK2 induces neuronal degeneration","volume":"102","author":"Smith","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.11.043_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/hmg\/ddm080","article-title":"Apoptotic mechanisms in mutant LRRK2-mediated cell death","volume":"16","author":"Iaccarino","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2009.11.043_bib28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2008.06.016","article-title":"Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway","volume":"32","author":"Liou","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2009.11.043_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-3-3","article-title":"Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons","volume":"3","author":"Wang","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbrc.2009.11.043_bib30","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2009.11.043_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.nbd.2005.09.001","article-title":"Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits","volume":"21","author":"Andrews","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2009.11.043_bib32","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1096\/fj.05-3845fje","article-title":"Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra","volume":"19","author":"von Bohlen und Halbach","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2009.11.043_bib33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.neuron.2008.07.021","article-title":"p73 regulates neurodegeneration and phospho-tau accumulation during aging and Alzheimer\u2019s disease","volume":"59","author":"Wetzel","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2009.11.043_bib34","doi-asserted-by":"crossref","first-page":"16906","DOI":"10.1074\/jbc.M708718200","article-title":"The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation","volume":"283","author":"Greggio","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.11.043_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.410440312","article-title":"Dominant negative effect of GTP cyclohydrolase I mutations in dopa-responsive hereditary progressive dystonia","volume":"44","author":"Hirano","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2009.11.043_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/1531-8249(200010)48:4<609::AID-ANA7>3.0.CO;2-H","article-title":"Dopa-responsive dystonia is induced by a dominant-negative mechanism","volume":"48","author":"Hwu","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2009.11.043_bib37","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/j.1460-2075.1990.tb08305.x","article-title":"Molecular bases of dominant negative and loss of function mutations at the murine c-kit\/white spotting locus: W37, Wv, W41 and W","volume":"9","author":"Nocka","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2009.11.043_bib38","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1073\/pnas.88.19.8696","article-title":"Mutation of the KIT (mast\/stem cell growth factor receptor) protooncogene in human piebaldism","volume":"88","author":"Giebel","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09022177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09022177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:21:30Z","timestamp":1762093290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X09022177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0006291X09022177"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.043","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}